Mô hình các bệnh kèm theo và tỷ lệ tử vong sau 1 năm ở bệnh nhân cao tuổi mắc COPD được nhập viện tại các khoa nội: dữ liệu từ Đăng ký RePoSI

Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3:e442 Fabbri LM, Luppi F, Beghe B et al (2008) Complex chronic comorbidities of COPD. Eur Respir J 31:204–212 Agusti A, Calverley PM, Celli B et al (2010) Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 11:122 Cavaillès A, Brinchault-Rabin G, Dixmier A et al (2013) Comorbidities of COPD. Eur Respir Rev 22:454–475 Divo M, Cote C, de Torres JP, BODE Collaborative Group et al (2012) Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186(2):155–161 Battaglia S, Basile M, Spatafora M et al (2015) Are asthmatics enrolled in randomized trials representative of real-life outpatients? Respiration 89:383–389 Scichilone N, Basile M, Battaglia S et al (2014) What proportion of chronic obstructive pulmonary disease outpatients is eligible for inclusion in randomized clinical trials? Respiration 87(1):11–17 The REPOSI registry of multimorbidity and polypharmacy: http://www.reposi.org. Accessed 12 Dec 2018 Katzman R, Brown T, Fuld P et al (1983) Validation of a short Orientation–Memory–Concentration Test of cognitive impairment. Am J Psychiatry 140:734–739 Hickie C, Snowdon J (1987) Depression scales for the elderly: gDS, Gilleard, Zung. Clin Gerontol J Aging Ment Health. 6:51–53 Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel index. Md State Med J. 14:61–65 Linn BS, Linn MW, Gurel L (1968) Cumulative illness rating scale. J Am Geriatr Soc 16:622–626 Levey AS, Stevens LA, Schmid CH, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med. 150:604–612 Hosmer DW, Lemeshow S (2000) Multiple logistic regression. In: Hosmer DW, Lemeshow S (eds) Applied logistic regression, 2nd edn. J Wiley; New York, NY, pp 31–46 Aramburu A, Arostegui I, Moraza J et al (2019) COPD classification models and mortality prediction capacity. Int J Chron Obstruct Pulmon Dis. 14:605–613 Yin HL, Yin SQ, Lin QY et al (2017) Prevalence of comorbidities in chronic obstructive pulmonary disease patients: a meta-analysis. Medicine 96(19):e6836 Almagro P, Cabrera FJ, Diez J, Working Group on, COPD, Spanish Society of Internal Medicine et al (2012) Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest 142(5):1126–1133 Bloom CI, Ricciardi F, Smeeth L, Stone P, Quint JK (2019) Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care. BMC Med. 17(1):73 Corrao S, Santalucia P, Argano C, REPOSI Investigators et al (2014) Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study. Eur J Intern Med 25(7):617–623 Zewari S, Vos P, van den Elshout F et al (2017) Obesity in COPD: revealed and Unrevealed Issues. COPD 14(6):663–673 Schnell K, Weiss CO, Lee T et al (2012) The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med. 12:26 Schane RE, Walter LC, Dinno A et al (2008) Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med 23(11):1757–1762 Dodd JW, Charlton RA, van den Broek MD et al (2013) Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest 144(1):119–127 Yohannes AM, Chen W, Moga AM et al (2017) Cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: a systematic review and meta-analysis of observational studies. J Am Med Dir Assoc. 18(5):e1–451 Hanania NA, Sharma G, Sharafkhaneh A (2010) COPD in the elderly patient. Semin Respir Crit Care Med 31(5):596–606 Fried LP, Bandeen-Roche K, Kasper JD et al (1999) Association of comorbidity with disability in older women: the Women’s Health and Aging Study. J Clin Epidemiol 52(1):27–37 García-Pérez L, Linertová R, Lorenzo-Riera A et al (2011) Risk factors for hospital readmissions in elderly patients: a systematic review. QJM 104:639–651 Corrao S, Natoli G, Nobili A, RePoSI Investigators et al (2019) Comorbidity does not mean clinical complexity: evidence from the RePoSI register. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02211-3 Ozyilmaz E, Kokturk N, Teksut G et al (2013) Unsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary disease. Int J Clin Pract 67(7):691–697 Ershler WB, Chen K, Reyes EB et al (2005) Economic burden of patients with anemia in selected diseases. Value Health. 8(6):629–638 Cote C, Zilberberg MD, Mody SH et al (2007) Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 29(5):923–929 Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352(10):1011–1023 Corrao S, Argano C, Natoli G, REPOSI Investigators et al (2018) Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia. Eur J Intern Med. 54:53–59 Lanièce I, Couturier P, Dramé M et al (2008) Incidence and main factors associated with early unplanned hospital readmission among French medical inpatients aged 75 and over admitted through emergency units. Age Ageing 37(4):416–422 Lohman MC, Scherer EA, Whiteman KL et al (2018) Factors Associated With Accelerated Hospitalization and Re-hospitalization Among Medicare Home Health Patients. J Gerontol A Biol Sci Med Sci 73(9):1280–1286 Wang Y, Stavem K, Dahl FA et al (2014) Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Int J Chron Obstruct Pulmon Dis. 9:99–105 Barabási AL, Gulbahce N, Loscalzo J (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12(1):56–68 Fabbri LM, Rabe KF (2007) From COPD to chronic systemic inflammatory syndrome? Lancet 370(9589):797–799 Franceschi C, Campisi J (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. Suppl 1:S4–S9 Miller J, Edwards LD, Agustí A, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators et al (2013) Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med 107(9):1376–1384 Thomsen M, Dahl M, Lange P et al (2012) Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186(10):982–988 Agustí A, Edwards LD, Rennard SI, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators et al (2012) Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 7(5):e37483 Vanfleteren LE, Spruit MA, Groenen M et al (2013) Clusters of Comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187(7):728–735 Kim YR, Hwang IC, Lee YJ et al (2018) Stroke risk among patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Clinics. 73:e177 Baty F, Putora PM, Isenring B et al (2013) Comorbidities and burden of COPD: a population-based case-control study. PLoS ONE 8(5):e63285 Sundh J, Ställberg B, Lisspers K et al (2011) Co-morbidity, body mass index and quality of life in COPD using the Clinical COPD Questionnaire. COPD 8(3):173–181 Mannino DM, Higuchi K, Yu TC et al (2015) Economic burden of COPD in the presence of comorbidities. Chest 148:138–150 Horita N, Goto A, Shibata Y et al (2017) Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev 2:CD012066 Ernst P, Saad N, Suissa S (2015) Inhaled corticosteroids in COPD: the clinical evidence. Eur Respir J 45(2):525–537 Simonetti AF, Viasus D, Garcia-Vidal C et al (2014) Management of community-acquired pneumonia in older adults. Ther Adv Infect Dis 2(1):3–16 Vitacca M, Paneroni M, Baiardi P et al (2016) Development of a Barthel Index based on dyspnea for patients with respiratory diseases. International Journal of Chronic Obstructive Pulmonary Disease. 11:1199–1206 Formiga F, Ferrer A, Padros G et al (2016) Evidence of functional declining and global comorbidity measured at baseline proved to be the strongest predictors for long-term death in elderly community residents aged 85 years: a 5-year follow-up evaluation, the OCTABAIX study. Clin Interv Aging 11:437–444 Singanayagam A, Schembri S, Chalmers JD (2013) Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc 10(2):81–89 Mapel D (2014) Renal and hepatobiliary dysfunction in chronic obstructive pulmonary disease. Curr Opin Pulm Med 20(2):186–193 Satish S, Freeman DH Jr, Ray L, Goodwin JS (2001) The relationship between blood pressure and mortality in the oldest old. J Am Geriatr Soc 49(4):367–374 Odden MC, Peralta CA, Haan MN et al (2012) Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. Arch Intern Med 172:1162–1168 Zhang XE, Cheng B, Wang Q (2016) Relationship between high blood pressure and cardiovascular outcomes in elderly frail patients: a systematic review and meta-analysis. Geriatr Nurs. 37(5):385–392 Post Hospers G, Smulders YM, Maier AB, Deeg DJ, Muller M (2015) Relation between blood pressure and mortality risk in an older population: role of chronological and biological age. J Intern Med 277(4):488–497 Corrao S, Argano C, Natoli G, REPOSI Investigators et al (2019) Sex-differences in the pattern of comorbidities, functional independence, and mortality in elderly inpatients: evidence from the RePoSI Register. J Clin Med 8(1):81